Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA).
about
Rational Design of Broad Spectrum Antibacterial Activity Based on a Clinically Relevant Enoyl-Acyl Carrier Protein (ACP) Reductase InhibitorResistance Mechanisms and the Future of Bacterial Enoyl-Acyl Carrier Protein Reductase (FabI) AntibioticsMethicillin-resistant Staphylococcus aureus: an evolutionary, epidemiologic, and therapeutic odysseyTriclosan promotes Staphylococcus aureus nasal colonizationTriclosan: A Widespread Environmental Toxicant with Many Biological EffectsStaphylococcus epidermidis isolated in 1965 are more susceptible to triclosan than current isolates.Acinetobacter baumannii: emergence of a successful pathogenThe impact of triclosan on the spread of antibiotic resistance in the environment.Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression.Chronic exposure to triclosan sustains microbial community shifts and alters antibiotic resistance gene levels in anaerobic digesters.Identification and characterization of TriABC-OpmH, a triclosan efflux pump of Pseudomonas aeruginosa requiring two membrane fusion proteinsEnvironmental fatty acids enable emergence of infectious Staphylococcus aureus resistant to FASII-targeted antimicrobials.Resistance to AFN-1252 arises from missense mutations in Staphylococcus aureus enoyl-acyl carrier protein reductase (FabI).Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns.Clinical Relevance of Type II Fatty Acid Synthesis Bypass in Staphylococcus aureus.New anti-infective coatings of surgical sutures based on a combination of antiseptics and fatty acids.Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureus.Triclosan exposure, transformation, and human health effects.
P2860
Q27683440-EB9726C8-662E-4715-9007-67C8653A378DQ28069943-C3F79844-6FFF-4C27-AFF8-368444D06272Q28235095-7DDD84D6-9F7C-41C0-B04B-5FC7FC82D6BBQ28384355-010F31B3-FFC1-4DC9-BE24-C34DA85833C4Q28388611-BFC4EE84-0282-4C12-AB98-0D43649AAB1DQ34685701-E7FC1394-36B4-45C7-A910-4FC2A5A68F6CQ34795807-A9DDA914-F19D-4986-AFB2-BE289371BCC7Q34969983-1DAD6815-264F-4919-A647-E4C7EA28570DQ35618052-FF62B19E-3A15-4957-B03D-E102CA7381C8Q36049667-35BC2917-CE9F-4A12-9024-0FD1C36C8F95Q36314900-D941C491-B9FA-4C7B-9F81-1BF9A4FC058DQ37329885-5A01A7B6-30C1-4CE5-BD6C-9EA76B7E79A0Q37404976-29551376-36F7-4467-9C8D-BA90E7224223Q38673550-307BBE18-189E-4BDE-9404-376FE1A8D1E4Q40334483-B53B6505-1A5E-4D21-B7E3-636543E8F23FQ44780131-4E79310C-DC99-4BA4-9513-B0CEE41A1C1AQ46130421-BC101EAF-2281-479D-BFDB-014DE246A01FQ47306831-D561DFCC-96DF-434D-8DC8-E371D14D00B6
P2860
Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA).
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA).
@en
Triclosan resistance in methicillin-resistant Staphylococcus aureus
@nl
type
label
Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA).
@en
Triclosan resistance in methicillin-resistant Staphylococcus aureus
@nl
prefLabel
Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA).
@en
Triclosan resistance in methicillin-resistant Staphylococcus aureus
@nl
P1476
Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA).
@en
P2093
Brenwald NP
P304
P356
10.1016/S0195-6701(03)00222-6
P577
2003-10-01T00:00:00Z